Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2014-12-22 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FORT-DE-FRANCE (97200), Martinique
NOUVELLE PHARMACIE DE BELLEVUE : revenue, balance sheet and financial ratios
NOUVELLE PHARMACIE DE BELLEVUE is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FORT-DE-FRANCE (97200),
this company of category PME
shows in 2021 a revenue of 1.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - NOUVELLE PHARMACIE DE BELLEVUE (SIREN 808584064)
Indicator
2025
2024
2023
2021
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
1 024 668 €
878 128 €
841 174 €
770 991 €
834 510 €
Net income
-42 435 €
-170 486 €
-36 199 €
24 446 €
40 087 €
10 514 €
-2 266 €
31 274 €
EBITDA
N/C
N/C
N/C
30 873 €
55 974 €
19 354 €
17 914 €
76 500 €
Net margin
N/C
N/C
N/C
2.4%
4.6%
1.2%
-0.3%
3.7%
Revenue and income statement
Im Jahr 2025 verzeichnet NOUVELLE PHARMACIE DE BELLEVUE einen Nettoverlust von 42 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-42 435 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt -734%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht -9%. Geringe Autonomie: Das Unternehmen ist stark von externer Finanzierung abhängig.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-734.407%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-9.081%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution NOUVELLE PHARMACIE DE BELLEVUE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2023
2024
2025
Debt ratio
704.414
693.328
546.763
285.103
155.306
328.368
-1557.392
-734.407
Financial autonomy
8.665
9.28
11.198
19.76
28.57
17.643
-4.26
-9.081
Repayment capacity
6.816
37.775
29.38
7.859
8.605
None
None
None
Cash flow / Revenue
6.35%
1.147%
1.247%
4.115%
2.707%
None%
None%
None%
Sector positioning
Verschuldungsgrad
-734.412025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Ausgezeichnet-50 pts over 3 years
Im Jahr 2025 liegt in den unteren 25% der Branche, was positiv ist das verschuldungsgrad von NOUVELLE PHARMACIE DE BEL... (-734.41). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Ein niedriges Verhältnis zeigt eine solide Finanzstruktur mit geringer Abhängigkeit von Gläubigern.
Finanzielle Autonomie
-9.08%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Beobachten
Im Jahr 2025 liegt in den unteren 25% der Branche das finanzielle autonomie von NOUVELLE PHARMACIE DE BEL... (-9.1%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Geringe Autonomie kann die Investitionsfähigkeit einschränken und die Verwundbarkeit erhöhen.
Liquidity ratios
Die Liquiditätsquote beträgt 62.22. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
62.224
Liquidity indicators evolution NOUVELLE PHARMACIE DE BELLEVUE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2021
2023
2024
2025
Liquidity ratio
130.66
126.249
114.857
131.119
127.138
115.631
72.475
62.224
Interest coverage
22.953
86.882
76.93
24.411
35.481
None
None
None
Sector positioning
Liquiditätsquote
62.222025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Beobachten-9 pts over 3 years
Im Jahr 2025 liegt in den unteren 25% der Branche das liquiditätsquote von NOUVELLE PHARMACIE DE BEL... (62.22). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.
Working capital requirement (WCR) and payment terms
Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution NOUVELLE PHARMACIE DE BELLEVUE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2023
2024
2025
Operating WCR
122 915 €
118 925 €
114 038 €
98 605 €
103 778 €
0 €
0 €
0 €
Inventory turnover (days)
58
56
48
41
42
0
0
0
Customer payment term (days)
6
5
7
5
2
0
0
0
Supplier payment term (days)
76
77
70
53
51
0
0
0
Positioning of NOUVELLE PHARMACIE DE BELLEVUE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare NOUVELLE PHARMACIE DE BELLEVUE with other companies in the same sector:
Frequently asked questions about NOUVELLE PHARMACIE DE BELLEVUE
What is the revenue of NOUVELLE PHARMACIE DE BELLEVUE ?
The revenue of NOUVELLE PHARMACIE DE BELLEVUE in 2021 is 1.0 M€.
Is NOUVELLE PHARMACIE DE BELLEVUE profitable?
NOUVELLE PHARMACIE DE BELLEVUE recorded a net loss in 2025.
Where is the headquarters of NOUVELLE PHARMACIE DE BELLEVUE ?
The headquarters of NOUVELLE PHARMACIE DE BELLEVUE is located in FORT-DE-FRANCE (97200), in the department Martinique.
Where to find the tax return of NOUVELLE PHARMACIE DE BELLEVUE ?
The tax return of NOUVELLE PHARMACIE DE BELLEVUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does NOUVELLE PHARMACIE DE BELLEVUE operate?
NOUVELLE PHARMACIE DE BELLEVUE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart